References
Viedt C, Fei J, Krieger-Brauer HI, Brandes RP, Teupser D, Kamimura M, Katus HA, Kreuzer J (2003) Role of p22phox in angiotensin II and platelet-derived growth factor AA induced activator protein 1 activation in vascular smooth muscle cells. J Mol Med (http://dx.doi.org/10.1007/s00109-003-0500-5)
Griendling KK, Sorescu D, Ushio-Fukai M (2000) NAD(P)H oxidase: role in cardiovascular disease. Circ Res 86:494–501
Griendling KK, Sorescu D, Lassègue, Ushio-Fukai M (2000) Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 20:2175–2183
Lassègue B, Clempus RE (2003) Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol 285:R277–297
Müller JM, Rupec RA, Baeuerle PA (1997) Study of gene regulation by NF-kB and AP-1 in response to reactive oxygen intermediates. Methods 11:301–312
Schlesinger TK, Fanger GR, Yujiri T, Johnson GL (1998) The TAO of MEKK. Front Biosci 15:D1181–1186
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Luft, F.C. A very phoxy business. J Mol Med 82, 1–3 (2004). https://doi.org/10.1007/s00109-003-0513-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-003-0513-0